Predictors of long-term survival in patients with lung cancer included in the Randomized Spanish Lung Cancer Group 0008 Phase II trial using concomitant chemoradiation with docetaxel and carboplatin plus induction or consolidation chemotherapy

1. Garrido, P.
2. Rosell, R.
3. Massutí, B.
4. Cardenal, F.
5. Alberola, V.
6. Dómine, M.
7. Maeztu, I.
8. Ramos, A.
9. Arellano, A.